Jumpcan Pharmaceutical
↗Taixing, Jiangsu, China
Jumpcan Pharmaceutical is a leading Chinese pharmaceutical group that integrates the research, development, manufacturing, and trading of Traditional Chinese Medicine (TCM), modern Western medicines, and health products. It is recognized as one of the Top 100 Pharmaceutical Manufacturers in China and is a key enterprise under the National Torch Program.
The company has established a dominant market position in several therapeutic areas, particularly pediatrics, where its flagship products like Pudilan Anti-inflammatory Oral Liquid and Xiao'er Chi Qiao Qing Re Granules are market leaders. In recent years, Jumpcan has aggressively shifted toward innovative drug development through strategic licensing deals and international partnerships to expand its pipeline beyond traditional medicine.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:TCM and Innovative Biopharma
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$850M-$1.1B
Founded:1997
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:China Southern Asset Management, Yinhua Fund Management, China Asset Management
STOCK
Exchange:Shanghai Stock Exchange
Ticker:600566.SS
Market Cap:$3.74B
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 3
Modalities:Small molecule, Biologics, TCM (Traditional Chinese Medicine), Nasal Spray
Active Trials:7
Trial Phases:Phase 1: 2 | Phase 2: 2 | Phase 3: 3
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Jiangsu Jumpcan Pharmaceutical Group Co., Ltd.
Subsidiaries:Tianji Pharmaceutical, Jiyuan Medicine, Pudilan Daily Use Chemicals, Shanghai Jijia Investment
Key Partnerships:I-Mab (Eftansomatropin alfa), Akeso (Ebronucimab), Puqi Pharmaceutical (Pumecitinib), Zederman Pharmaceutical (Benvitimod)
COMPETITION
Position:Leader
Competitors:Shijiazhuang Yiling Pharmaceutical, Shandong Buchang Pharmaceuticals, China Resources Sanjiu, Tasly Pharmaceutical
LEADERSHIP
Key Executives:
Longxiang Cao - Chairman
Fei Cao - CEO / General Manager
Board Members:Qu Rong Huang, Wei Cao, Chaojun Lu
LINKS
Website:jumpcan.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Jumpcan Pharmaceutical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.